Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: A comparison to T2-weighted cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Ferreira, Vanessa M ^a,b   Piechnik, Stefan K ^a   Dallarmellina, Erica ^a   Karamitsos, Theodoros D ^a   Francis, Jane M ^a   Choudhury, Robin P ^a   Friedrich, Matthias G ^b,c   Robson, Matthew D ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiovascular magnetic resonance; Myocardial edema; ShMOLLI; T1 mapping; T2 weighted MRI

Indexed keywords

GADODIAMIDE; TROPONIN I;

ACUTE MYOCARDIAL EDEMA; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; TAKOTSUBO CARDIOMYOPATHY;

EID: 84862489811     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-42     Document Type: Article

References (31)

1. Myocardial edema-a new clinical entity? Friedrich MG, Nature Reviews Cardiology 2010 7 292 296 20309007
2. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R, Friedrich MG, Circulation 2004 109 2411 2416 10.1161/01.CIR.0000127428.10985.C6 15123531 (Pubitemid 38679560)
3. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Payne AR, Casey M, McClure J, McGeoch R, Murphy A, Woodward R, Saul A, Bi X, Zuehlsdorff S, Oldroyd KG, et al. Circulation: Cardiovascular Imaging 2011 4 210 219
4. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF, Arai AE, Circulation 2006 113 1865 1870 10.1161/CIRCULATIONAHA.105. 576025 16606793 (Pubitemid 43739398)
5. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, et al. Journal of the American College of Cardiology 2009 53 1475 1487 10.1016/j.jacc.2009.02.007 19389557
6. T2-weighted cardiovascular magnetic resonance imaging. Abdel-Aty H, Simonetti O, Friedrich MG, Journal of Magnetic Resonance Imaging 2007 26 452 459 10.1002/jmri.21028 17729358 (Pubitemid 350194566)
7. CMR for characterization of the myocardium in acute coronary syndromes. Dall'Armellina E, Karamitsos TD, Neubauer S, Choudhury RP, Nature Reviews Cardiology 2010 7 624 636 10.1038/nrcardio.2010.140 20856263
8. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Simonetti OP, Finn JP, White RD, Laub G, Henry DA, Radiology 1996 199 49 57 8633172
9. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE, Magnetic Resonance in Medicine 2007 57 891 897 10.1002/mrm.21215 17457880 (Pubitemid 46709409)
10. ACUT2E TSE-SSFP: A hybrid method for T2-weighted imaging of edema in the heart. Aletras AH, Kellman P, Derbyshire JA, Arai AE, Magnetic Resonance in Medicine 2008 59 229 235 10.1002/mrm.21490 18228588 (Pubitemid 351220085)
11. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100MHz: Dependence on tissue type, NMR frequency, temperature, species, excision, and age. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM, Medical Physics 1984 11 425 448 10.1118/1.595535 6482839 (Pubitemid 14057394)
12. Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage. Arai AE, Journal of Cardiovascular Pharmacology and Therapeutics 2011 16 313 320 10.1177/1074248411412378 21821534
13. Prolongation of proton spin lattice relaxation times in regionally ischemic tissue from dog hearts. Williams ES, Kaplan JI, Thatcher F, Journal of Nuclear Medicine 1980 21 449 453 7373415 (Pubitemid 10105846)
14. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU, Magnetic Resonance in Medicine 2007 58 34 40 10.1002/mrm.21272 17659622 (Pubitemid 47229915)
15. Cardiovascular magnetic resonance by non contrast T1 mapping allows assessment of severity of injury in acute myocardial infarction. Dall'Armellina E, Piechnik S, Ferreira V, Si QL, Robson M, Francis J, Cuculi F, Kharbanda R, Banning A, Choudhury R, et al. Journal of Cardiovascular Magnetic Resonance 2012 14 15 10.1186/1532-429X-14-15 22309452
16. Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD: Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. Piechnik SK, Ferreira VM, J Cardiovasc Magn Reson 2010 12 69 10.1186/1532-429X-12-69 21092095
17. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. Eitel I, Von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, et al. JAMA-Journal of the American Medical Association 2011 306 277 286 10.1001/jama.2011.992
18. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magnetic Resonance in Medicine 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
19. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J, Journal of the American College of Cardiology 2005 45 1815 1822 10.1016/j.jacc.2004.11.069 15936612 (Pubitemid 40779862)
20. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. DeLong ER, DeLong DM, Clarke-Pearson DL, Biometrics 1988 44 837 845 10.2307/2531595 3203132
21. Statistical methods for assessing agreement between two methods of clinical measurement. Bland JM, Altman DG, Lancet 1986 1 307 310 2868172 (Pubitemid 16134762)
22. Molecular imaging: T2-weighted CMR of the area at riskg-a risky business? Wince WB, Kim RJ, Nature Reviews Cardiology 2010 7 547 549 10.1038/nrcardio. 2010.124 20865026
23. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: Insights from T2-weighted cardiovascular magnetic resonance. Abdel-Aty H, Cocker M, Friedrich MG, International Journal of Cardiology 2009 132 291 293 10.1016/j.ijcard.2007.08. 102 18086501
24. Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eitel I, Lücke C, Grothoff M, Sareban M, Schuler G, Thiele H, Gutberlet M, European Radiology 2010 20 422 431 10.1007/s00330-009-1549-5 19705125
25. Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Bragadeesh T, Jayaweera AR, Pascotto M, Micari A, Le DE, Kramer CM, Epstein FH, Kaul S, Heart 2008 94 166 171 10.1136/hrt.2006.102434 17639092 (Pubitemid 351211722)
26. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: A 1-year follow-up study. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P, Chest 2002 122 1895 1901 10.1378/chest.122.6.1895 12475823 (Pubitemid 36051121)
27. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
28. Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, Journal of the American College of Cardiology 2008 52 1574 1580 10.1016/j.jacc.2008.06.049 19007595
29. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU, Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study AJR, American journal of roentgenology 2006 187
30. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. Krombach GA, Hahn C, Tomars M, Buecker A, Grawe A, Günther RW, Kühl HP, Journal of Magnetic Resonance Imaging 2007 25 1283 1287 17520735 (Pubitemid 46870288)
31. Thavendiranathan P, Walls M, Giri S, Verhaert D, Rajagopalan S, Moore S, Simonetti OP, Raman SV: Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping Cardiovascular Imaging Epub ahead of print, Circulation 2011 Oct 28